TradeInsight.info
Trade Insight
By Trade
Congress Trade
Insider Trade
Latest Trade
By Insider
Congress Members
Corporate Insiders
More
Features
Pricing
Toggle Sidebar
TradeInsight.info
By Trade
By Insider
Features
Pricing
Search...
⌘
K
Sign In
Try for Free
Previous
1/1
Next
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our
Terms of Service
and
Privacy Policy
.
Email
Password
Forgot your password?
Login
Trade Date*
Filing Date*
Insider Name
Buy/Sell
Company Name
Ticker
Price*
Amount
Shares Change
Mar 05, 2025
Mar 08, 2025
Henderson Michael Thomas
CEO
Sell
Apogee Therapeutics, Inc.
APGE
$30.15
$301,511
-0.77%
Feb 05, 2025
Feb 08, 2025
Henderson Michael Thomas
CEO
Sell
Apogee Therapeutics, Inc.
APGE
$40.58
$608,700
-1.14%
Jan 08, 2025
Jan 11, 2025
Henderson Michael Thomas
CEO
Sell
Apogee Therapeutics, Inc.
APGE
$48.85
$732,693
-1.13%
Dec 04, 2024
Dec 07, 2024
Henderson Michael Thomas
CEO
Sell
Apogee Therapeutics, Inc.
APGE
$46.58
$698,654
-1.12%
Nov 06, 2024
Nov 09, 2024
Henderson Michael Thomas
CEO
Sell
Apogee Therapeutics, Inc.
APGE
$59.22
$888,320
-1.11%
Oct 02, 2024
Oct 05, 2024
Henderson Michael Thomas
CEO
Sell
Apogee Therapeutics, Inc.
APGE
$56.23
$2M
-2.87%
Sep 04, 2024
Sep 07, 2024
Henderson Michael Thomas
CEO
Sell
Apogee Therapeutics, Inc.
APGE
$47.62
$2M
-2.79%
Aug 07, 2024
Aug 10, 2024
Henderson Michael Thomas
CEO
Sell
Apogee Therapeutics, Inc.
APGE
$40.62
$2M
-2.71%
Jul 05, 2024
Jul 06, 2024
Henderson Michael Thomas
CEO
Sell
Apogee Therapeutics, Inc.
APGE
$37.26
$558,900
-1.01%
Dec 01, 2020
Dec 02, 2020
Henderson Michael Thomas
Chief Business Officer
Sell
Bridgebio Pharma, Inc.
BBIO
$51.52
$515,204
-3.52%
Jun 03, 2020
Dec 02, 2020
Henderson Michael Thomas
Chief Business Officer
Sell
Bridgebio Pharma, Inc.
BBIO
$30.04
$23,549
-0.30%
Nov 16, 2020
Nov 19, 2020
Henderson Michael Thomas
Chief Business Officer
Sell
Bridgebio Pharma, Inc.
BBIO
$45
$450,000
-3.52%
Nov 02, 2020
Nov 03, 2020
Henderson Michael Thomas
Chief Business Officer
Sell
Bridgebio Pharma, Inc.
BBIO
$38.36
$383,558
-3.60%
Oct 01, 2020
Oct 05, 2020
Henderson Michael Thomas
Chief Business Officer
Sell
Bridgebio Pharma, Inc.
BBIO
$38.83
$388,342
-3.60%
Sep 18, 2020
Sep 22, 2020
Henderson Michael Thomas
Chief Business Officer
Sell
Bridgebio Pharma, Inc.
BBIO
$40
$400,000
-3.60%
Sep 01, 2020
Sep 03, 2020
Henderson Michael Thomas
Chief Business Officer
Sell
Bridgebio Pharma, Inc.
BBIO
$28.73
$287,334
-3.60%
Aug 03, 2020
Aug 05, 2020
Henderson Michael Thomas
Chief Business Officer
Sell
Bridgebio Pharma, Inc.
BBIO
$27.37
$273,741
-3.70%
Jul 01, 2020
Jul 06, 2020
Henderson Michael Thomas
Chief Business Officer
Sell
Bridgebio Pharma, Inc.
BBIO
$30.97
$309,701
-3.70%
Jun 08, 2020
Jun 10, 2020
Henderson Michael Thomas
Chief Business Officer
Sell
Bridgebio Pharma, Inc.
BBIO
$30.01
$18,185
-0.23%
Jun 01, 2020
Jun 03, 2020
Henderson Michael Thomas
Chief Business Officer
Sell
Bridgebio Pharma, Inc.
BBIO
$29.37
$75,912
-0.98%
May 05, 2020
May 07, 2020
Henderson Michael Thomas
Sell
Bridgebio Pharma, Inc.
BBIO
$30.47
$44,493
-0.89%
May 01, 2020
May 05, 2020
Henderson Michael Thomas
Sell
Bridgebio Pharma, Inc.
BBIO
$29.52
$115,267
-2.33%
Apr 01, 2020
Apr 03, 2020
Henderson Michael Thomas
Sell
Bridgebio Pharma, Inc.
BBIO
$26.94
$69,629
-1.52%
Mar 02, 2020
Mar 04, 2020
Henderson Michael Thomas
Sell
Bridgebio Pharma, Inc.
BBIO
$32.44
$128,965
-2.28%
Feb 03, 2020
Feb 05, 2020
Henderson Michael Thomas
Sell
Bridgebio Pharma, Inc.
BBIO
$34.9
$138,729
-2.23%
Jan 02, 2020
Jan 07, 2020
Henderson Michael Thomas
Sell
Bridgebio Pharma, Inc.
BBIO
$33.17
$131,861
-2.18%
Jul 01, 2019
Jul 03, 2019
Henderson Michael Thomas
Buy
Bridgebio Pharma, Inc.
BBIO
$17
$119,000
+3.73%